BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS
Clinical trials for BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS explained in plain language.
Never miss a new study
Get alerted when new BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS trials appear
Sign up with your email to follow new studies for BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shielding hearts from Chemo's toxic blow in blood cancer battle
Disease control Recruiting nowThis study is testing whether a drug called dexrazoxane can protect the heart from damage caused by powerful chemotherapy used to treat aggressive blood cancers like acute myeloid leukemia. It will enroll 100 patients with these cancers who are receiving a specific combination of…
Matched conditions: BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug cocktail aims to knock out tough blood cancers
Disease control Recruiting nowThis study is testing a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) to see how well they work against aggressive forms of blood cancer, including acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), and chronic my…
Matched conditions: BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC